Bristol-Myers Squibb is a leading pharmaceutical company with a strong pipeline. However, the stock is been stagnant in 2020 and therefore remains significantly undervalued here at the beginning of 2021. With this video I attempt to illustrate reasons why the market has been neglecting this blue-chip and then elaborate on whether it is justified or not.
— Chuck Carnevale
"I have $358 Million Riding on This Next-Gen AI Breakthrough" [sponsor]
Legendary fund manager Louis Navellier – a man Forbes calls "the king of quants" – is going "ALL-IN" on this game-changing AI technology. He says, "This is the culmination of everything you've been reading about AI for the last 60 years."Get the details...
Legendary fund manager Louis Navellier – a man Forbes calls "the king of quants" – is going "ALL-IN" on this game-changing AI technology. He says, "This is the culmination of everything you've been reading about AI for the last 60 years."Get the details...
Source: FAST Graphs
